Jan De Witte Resmed Inc (RSMDF) insider trading activity

Jan De Witte is Director of RESMED INC. Currently has a direct ownership of 4,261 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Nov 25, 2025, when has been sold 2,055 shares (ReMed Common Stock) at a price of $255.0 per share, resulting in proceeds of $524,025. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.26K

26.61% 3M change

45.41% 12M change

Total Value Held $0

Jan De Witte Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 25 2025	SELL Open market or private sale	$524,025 $255.0 p/Share	2,055 Reduced 32.54%	4,261 ReMed Common Stock
Nov 20 2025	BUY Grant, award, or other acquisition	-	1,073 Added 14.52%	6,316 ReMed Common Stock
Nov 11 2025	SELL Payment of exercise price or tax liability	$19,007 $250.1 p/Share	76 Reduced 1.43%	5,242 ReMed Common Stock
Nov 11 2025	SELL Open market or private sale	$121,871 $250.25 p/Share	487 Reduced 8.39%	5,319 ReMed Common Stock
May 20 2025	SELL Open market or private sale	$486,940 $243.47 p/Share	2,000 Reduced 25.62%	5,806 ReMed Common Stock
Nov 20 2024	BUY Grant, award, or other acquisition	-	1,083 Added 12.18%	7,806 ReMed Common Stock
Nov 12 2024	SELL Open market or private sale	$198,052 $248.81 p/Share	796 Reduced 10.59%	6,723 ReMed Common Stock

May 15 2024	SELL Open market or private sale	$78,584 $218.29 p/Share	360 Reduced 4.57%	7,519 ReMed Common Stock
Nov 16 2023	BUY Grant, award, or other acquisition	-	1,768 Added 18.33%	7,879 ReMed Common Stock
Nov 16 2022	BUY Grant, award, or other acquisition	-	1,122 Added 15.51%	6,111 ReMed Common Stock
Nov 18 2021	BUY Grant, award, or other acquisition	-	956 Added 16.08%	4,989 ResMed Common Stock
Nov 11 2021	SELL Payment of exercise price or tax liability	$26,985 $259.47 p/Share	104 Reduced 2.51%	4,033 ReMed Common Stock
Nov 27 2020	SELL Payment of exercise price or tax liability	$38,816 $212.11 p/Share	183 Reduced 4.24%	4,137 ReMed Common Stock
Nov 19 2020	BUY Grant, award, or other acquisition	-	1,187 Added 21.55%	4,320 ReMed Common Stock

Also insider at

IART

INTEGRA LIFESCIENCES HOLDINGS CORP Healthcare

President & CEO

JDW

Jan De Witte

Director

Princeton, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSMDF shares.

Notify only if

Value

Insider Trading

Get notified when an Resmed Inc insider buys or sells RSMDF shares.

Notify only if

Operation

Value

Type

News

Receive news related to RESMED INC

Track Activities on RSMDF

Account